Updated survival, efficacy and safety of adjuvant (adj) atezolizumab (atezo) after neoadjuvant (neoadj) atezo in the phase II LCMC3 study Meeting Abstract
| Authors: | Carbone, D. P.; Waqar, S. N.; Chaft, J.; Kris, M. G.; Johnson, B. E.; Lee, J. M.; Wistuba, I. I.; Kwiatkowski, D.; Bunn, P. A.; Schulze, K.; Johnson, A. M.; Brandao, E.; Awad, M.; Reckamp, K.; Chiang, A. C.; Nicholas, A.; Rusch, V. |
| Abstract Title: | Updated survival, efficacy and safety of adjuvant (adj) atezolizumab (atezo) after neoadjuvant (neoadj) atezo in the phase II LCMC3 study |
| Meeting Title: | 2023 European Lung Cancer Congress |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 18 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2023 Mar 29-Apr 1 |
| Meeting Location: | Copenhagen, Denmark |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2023-04-01 |
| Start Page: | S90 |
| End Page: | S91 |
| Language: | English |
| ACCESSION: | WOS:000995007600086 |
| PROVIDER: | wos |
| DOI: | 10.1016/S1556-0864(23)00339-8 |
| Notes: | Meeting Abstract: 145MO -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work